MedTrace Logo

To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBM

NCT03814772 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-02-21

No results posted yet for this study

Summary

Based on the principle of patient blood management, this study aims to reduce the risk of blood transfusion in allogeneic liver transplantation patients, to ensure the safety of blood transfusion, and to provide new methods and basis for restrictive blood transfusion.

Conditions

  • Blood Transfusion Complication

Interventions

PROCEDURE

Liver transplant

blood transfusion

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    collaborator OTHER

  • RenJi Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • The Third Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2019-12-01
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03814772 on ClinicalTrials.gov